Try our Advanced Search for more refined results
August 16, 1999
In Re: LORAZEPAM/CLORAZE, et al v. MYLAN LABORATORIES, et al
Case Number:
1:99-mc-00276
Court:
Nature of Suit:
Judge:
Firms
- Baker & Hostetler
- Baron & Budd
- Bennett LoCicero
- Blank Rome
- Boies Schiller
- Clifford Chance
- Crowell & Moring
- Debevoise & Plimpton
- Dorsey & Whitney
- Foley & Lardner
- Gibson Dunn
- Guttman Buschner
- Hausfeld LLP
- Hogan Lovells
- Hunton Andrews
- Jenner Law
- Kasowitz Benson
- Kellogg Hansen
- King & Spalding
- Latham & Watkins
- Leatherwood Walker
- Lowey Dannenberg
- Mayer Brown
- Morrison Foerster
- NastLaw
- Nichols Liu LLP
- Paul Weiss
- Pomerantz LLP
- Proskauer Rose
- Reed Smith
- Robins Kaplan
- Saul Ewing
- Shearman & Sterling
- Sheppard Mullin
- Shipman & Goodwin
- Weil Gotshal
- Wiley Rein
- Williams & Connolly
- Williams Hart
- Wilson Sonsini
- Zwerling Schachter
Companies
- Advocate Health Care Inc.
- Aetna Inc.
- BlueCross BlueShield of Massachusetts
- Blue Cross & Blue Shield of Minnesota
- BlueCross BlueShield of New Mexico
- BlueCross BlueShield of Texas
- Blue Shield of California
- Cambrex Corp.
- Cardinal Health Inc.
- Federated Mutual Insurance Co.
- Florida Blue
- Guardian Life Insurance Co. of America
- Gyma Laboratories of America Inc.
- Harvard Pilgrim Health Care Inc.
- Health Care Service Corp.
- Health Net Inc.
- Independence Blue Cross Inc.
- Medco Health Solutions Inc.
- Mutual of Omaha Insurance Co. Inc.
- Mylan NV
- Trustmark Corp.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 31, 2017
Mylan, Other Drugmakers Must Pay $67M In Antitrust Suit
The D.C. federal court has ordered generic-drug maker Mylan Pharmaceuticals and chemical companies Cambrex and Gyma Laboratories to pay a combined $67 million to Blue Cross Blue Shield of Massachusetts and three other insurers in a long-running suit accusing the three companies of violating state antitrust laws.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login